Neurologic manifestations of localized scleroderma: A case report and literature review

Neurology

Volumn 71, Issue 19, 2008, Pages 1538-1545

  Kister, Ilya ^a,d   Inglese, Matilde ^b   Laxer, Ronald M ^c   Herbert, Joseph ^a  

^a MS Care Center   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d NYU HOSPITAL FOR JOINT DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; METHOTREXATE; METHYLPREDNISOLONE; OLIGOCLONAL BAND; PREGABALIN; TOPIRAMATE; IMMUNOSUPPRESSIVE AGENT;

ADULT; BRAIN DAMAGE; CASE REPORT; CEREBROSPINAL FLUID; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEMIFACIAL ATROPHY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MIGRAINE; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAYNAUD PHENOMENON; REVIEW; SCLERODERMA; SEIZURE; SKIN INFLAMMATION; TONIC CLONIC SEIZURE; WHITE MATTER; ADOLESCENT; ARTICLE; BRAIN; BRAIN DISEASE; CHILD; INFANT; LITERATURE; LOCALIZED SCLERODERMA; MALE; PATHOLOGY; PATHOPHYSIOLOGY; PRESCHOOL CHILD;

ADOLESCENT; ADULT; BRAIN; BRAIN DISEASES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; MALE; REVIEW LITERATURE AS TOPIC; SCLERODERMA, LOCALIZED;

EID: 56149097854     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000334474.88923.e3     Document Type: Review

References (59)

1. Peterson LS, Nelson AM, Su WP, et al. The epidemiology of morphea (localized scleroderma) in Olmsted County 1960-1993. J Rheumatol 1997;24:73-80.
2. Zulian F, Athreya BH, Laxer R, et al. Juvenile localized scleroderma: clinical and epidemiological features in 750 children: an international study. Rheumatology (Oxford) 2006;45:614-620.
3. Marzano AV, Menni S, Parodi A, et al. Localized sclero-derma in adults and children: clinical and laboratory investigations on 239 cases. Eur J Dermatol 2003;13:171-176.
4. Appenzeller S, Montenegro MA, Dertkiggil SS, et al. Neuroimaging findings in scleroderma en coup de sabre. Neurology 2004;62:1585-1589.
5. Asher SW, Berg BO. Progressive hemifacial atrophy: report of three cases, including one observed over 43 years, and computed tomographic findings. Arch Neurol 1982; 39:44-46.
6. Aktekin B, Oguz Y, Aydin H, et al. Cortical silent period in a patient with focal epilepsy and Parry-Romberg syndrome. Epilepsy Behav 2005;6:270-273.
7. Carreño M, Donaire A, Barcelo MI, et al. Parry Romberg syndrome and linear scleroderma in coup de sabre mimicking Rasmussen encephalitis. Neurology 2007;68:1308-1310.
8. Chang GY, Park SH, Youn YC, et al. Neuroimaging findings in scleroderma en coup de sabre. Neurology 2004;63: 2197-2198.
9. Chapman MS, Peraza JE, Spencer SK. Parry-Romberg syndrome with contralateral and ipsilateral extremity involvement. J Cutan Med Surg 1999;3:260-262.
10. Chung MH, Sum J, Morrell MJ, et al. Intracerebral involvement in scleroderma en coup de sabre: report of a case with neuropathologic findings. Ann Neurol 1995;37:679-681.
11. Cory C, Clayman DA, Faillace WJ, et al. Clinical and radiologic findings in progressive facial hemiatrophy (Parry-Romberg syndrome). Am J Neuroradiol 1997;18: 751-757.
12. David J, Wilson J, Woo P. Scleroderma "en coup de sabre." Ann Rheum Dis 1991;50:260-262.
13. DeFelipe J, Segura T, Arellano JI, et al. Neuropathological findings in a patient with epilepsy and the Parry-Romberg syndrome. Epilepsia 2001;42:1198-1203.
14. Dupont S, Catala M, Hasboun D, et al. Progressive facial hemiatrophy and epilepsy: a common underlying dysgenetic mechanism. Neurology 1997;48:1013-1018.
15. Duyff RF, Vos J. A "scar" and epilepsy: coup de sabre. J Neurol Neurosurg Psychiatry 1998;65:568.
16. Flores-Alvarado DE, Esquivel-Valerio JA, Garza-Elizondo M, et al. Linear scleroderma en coup de sabre and brain calcification: is there a pathogenic relationship? J Rheumatol 2003;30:193-195.
17. Fry JA, Alvarellos A, Fink CW, et al. Intracranial findings in progressive facial hemiatrophy. J Rheumatol 1992;19: 956-958.
18. Gambichler T, Kreuter A, Hoffmann K, et al. Bilateral linear scleroderma "en coup de sabre" associated with facial atrophy and neurological complications. BMC Dermatol 2001;1:9.
19. Goldberg-Stern H, deGrauw T, Passo M, et al. Parry-Romberg syndrome: follow-up imaging during suppressive therapy. Neuroradiology 1997;39:873-876.
20. Grosso S, Fioravanti A, Biasi G, et al. Linear scleroderma associated with progressive brain atrophy. Brain Dev 2003; 25:57-61.
21. Higashi Y, Kanekura T, Fukumaru K, et al. Scleroderma en coup de sabre with central nervous system involvement. J Dermatol 2000;27:486-488.
22. Holl-Wieden A, Klink T, Klink J, et al. Linear scleroderma "en coup de sabre" associated with cerebral and ocular vasculitis. Scand J Rheumatol 2006;35:402-404.
23. Holland KE, Steffes B, Nocton JJ, et al. Linear scleroderma en coup de sabre with associated neurologic abnormalities. Pediatrics 2006;117:e132-136.
24. Kasapcopur O, Ozkan HC, Tuysuz B. Linear scleroderma en coup de sabre and brain calcification: is there a pathogenic relationship? J Rheumatol 2003;30:2724-2725.
25. Ledeman RJ. Progressive facial and cerebral hemiatrophy. Cleve Clin Q 1984 Fall; 51:545-548.
26. Liu P, Uziel Y, Chuang S, et al. Localized scleroderma: imaging features. Pediatr Radiol 1994;24:207-209.
27. Luer W, Jockel D, Henze T, et al. Progressive inflammatory lesions of the brain parenchyma in localized scleroderma of the head. J Neurol 1990;237:379-381.
28. Miedziak AI, Stefanyszyn M, Flanagan J, et al. Parry-Romberg syndrome associated with intracranial vascular malformations. Arch Ophthalmol 1998;116:1235-1237.
29. Menni S, Marzano AV, Passoni E. Neurologic abnormalities in two patients with facial hemiatrophy and sclerosis coexisting with morphea. Pediatr Dermatol 1997;14:113-116.
30. Moko SB, Mistry Y, Blandin De Chalain TM. Parry-Romberg syndrome: intracranial MRI appearances. J Craniomaxillofac Surg 2003;31:321-324.
31. Obermoser G, Pfausler BE, Linder DM, et al. Scleroderma en coup de sabre with central nervous system and ophthalmologic involvement: treatment of ocular symptoms with interferon gamma. J Am Acad Dermatol 2003;49:543-546.
32. Paprocka J, Jamroz E, Adamek D, et al. Difficulties in differentiation of Parry-Romberg syndrome, unilateral facial scleroderma, and Rasmussen syndrome. Childs Nerv Syst 2006;22:409-415.
33. Piette WW, Dorsey JK, Foucar E. Clinical and serologic expression of localized scleroderma: case report and review of the literature. J Am Acad Dermatol 1985;13(2 Pt 2): 342-350.
34. Pichiecchio A, Uggetti C, Grazia Egitto M, et al. Parry-Romberg syndrome with migraine and intracranial aneurysm. Neurology 2002;59:606-608; discussion 481.
35. Pupillo G, Andermann F, Dubeau F. Linear scleroderma and intractable epilepsy: neuropathologic evidence for a chronic inflammatory process. Ann Neurol 1996;39:277-278.
36. Ramboer K, Demaerel PH, Baert AL, et al. Linear scleroderma with orbital involvement: follow up and magnetic resonance imaging. Br J Ophthalmol 1997;81:90-93.
37. Sagild JC, Alving J. Hemiplegic migraine and progressive hemifacial atrophy. Ann Neurol 1985;17:620.
38. Sathornsumetee S, Schanberg L, Rabinovich E, et al. Parry-Romberg syndrome with fatal brain stem involvement. J Pediatr 2005;146:429-431.
39. Shah JR, Juhasz C, Kupsky WJ, et al. Rasmussen encephalitis associated with Parry-Romberg syndrome. Neurology 2003;61:395-397.
40. Stone J, Franks AJ, Guthrie JA, et al. Scleroderma "en coup de sabre": pathological evidence of intracerebral inflammation. J Neurol Neurosurg Psychiatry 2001;70:382-385.
41. Terstegge K, Kunath B, Felber S, et al. MR of brain involvement in progressive facial hemiatrophy (Romberg disease): reconsideration of a syndrome. AJNR Am J Neu-roradiol 1994;15:145-150.
42. Unterberger I, Trinka E, Engelhardt K, et al. Linear sclero-derma "en coup de sabre" coexisting with plaque-morphea: neuroradiological manifestation and response to corticoste-roids. J Neurol Neurosurg Psychiatry 2003;74:661-664.
43. Yano T, Sawaishi Y, Toyono M, et al. Progressive facial hemiatrophy after epileptic seizures. Pediatr Neurol 2000; 23:164-166.
44. Woolfenden AR, Tong DC, Norbash AM, et al. Progressive facial hemiatrophy: abnormality of intracranial vascu-lature. Neurology 1998;50:1915-1917.
45. Lederman RJ. Progressive facial and cerebral hemiatrophy. Cleve Clin Q 1984;545:548.
46. Tollefson MM, Witman PM. En coup de sabre morphea and Parry-Romberg syndrome: a retrospective review of 54 patients. J Am Acad Dermatol 2007;56:257-263.
47. Jablonska S, Blaszczyk M, Rosinska D. Progressive facial hemiat-rophy and scleroderma en coup de sabre: clinical presentation and course as related to the onset in early childhood and young adults. Arch Argent Dermatol 1998;48:125-128.
48. Korkmaz C, Adapinar B, Uysal S. Beneficial effect of immunosuppressive drugs on Parry-Romberg syndrome: a case report and review of the literature. South Med J 2005 Sep; 98:940-942.
49. Kreuter A, Gambichler T, Breuckmann F, et al. Pulsed high-dose corticosteroids combined with low-dose metho-trexate in severe localized scleroderma [erratum 2005;141: 1091]. Arch Dermatol 2005;141:847-852.
50. Zannin ME, Martini G, et al. Ocular involvement in children with localised scleroderma: a multi-centre study. Br J Ophthalmol 2007;91:1311-1314.
51. Stone J. Parry-Romberg syndrome: a global survey of 205 patients using the Internet. Neurology 2003;61:674-676.
52. Poser CM, Brinar VV. Epilepsy and multiple sclerosis. Epilepsy Behav 2003;4:6-12.
53. Blaszczyk M, Krolicki L, Bacharach-Buhles M, et al. Progressive facial hemiatrophy: central nervous system in- volvement and relationship with scleroderma en coup de sabre. J Rheumatol 2003;30:1997-2004.
54. Kornreich HK, King KK, Bernstein BH, et al. Scleroderma in childhood. Arthritis Rheum 1977;20(2 suppl):343-350.
55. Wolf SM, Verity MA. Neurological complications of progressive facial hemiatrophy. J Neurol Neurosurg Psychiatry 1994;37:997-1004.
56. Takehara K, Sato S. Localized scleroderma is an autoimmune disorder. Rheumatology (Oxford) 2005;44:274-279.
57. Bonilla G, Guerrerosantos J, Fritzler MJ. Autoantibodies in Parry-Romberg syndrome: a serologic study of 14 patients. J Rheumatol 1995;22:73-77.
58. Pansler JM, Murphy GF, Mulliken JB. Clinical and ultrastructural studies of Romberg's hemifacial atrophy. Plast Reconstr Surg 1990;85:669-674.
59. Chbicheb M, Gelot A, Rivier F, et al. Parry-Romberg's syndrome and epilepsy. Rev Neurol (Paris) 2005;161: 92-97.